Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew B. Maksymowych is active.

Publication


Featured researches published by Andrew B. Maksymowych.


Journal of Biological Chemistry | 1998

Binding and Transcytosis of Botulinum Neurotoxin by Polarized Human Colon Carcinoma Cells

Andrew B. Maksymowych; Lance L. Simpson

T-84 and Caco-2 human colon carcinoma cells and Madin-Darby canine kidney (MDCK) cells were used to study binding and transcytosis of iodinated Clostridium botulinum neurotoxin serotypes A, B, and C, as well as tetanus toxin. Specific binding and transcytosis were demonstrated for serotypes A and B in intestinal cells. Using serotype A as an example, the rate of transcytosis by T-84 cells was determined in both apical to basolateral (11.34 fmol/h/cm2) as well as basolateral to apical (8.98 fmol/h/cm2) directions, and by Caco-2 cells in the apical to basolateral (8.42 fmol/h/cm2) direction. Serotype A retained intact di-chain structure during transit through T-84 or Caco-2 cells, and when released on the basolateral side was toxicin vivo to mice and in vitro on mouse phrenic nerve-hemidiaphragm preparations. Serotype C and tetanus toxin did not bind effectively to T-84 cells, nor were they efficiently transcytosed (8–10% of serotype A). MDCK cells did not bind or efficiently transcytose (0.32 fmol/h/cm2) botulinum toxin. Further characterization demonstrated that the rate of transcytosis for serotype A in T-84 cells was increased 66% when vesicle sorting was disrupted by 5 μm brefeldin A, decreased 42% when microtubules were disrupted by 10 μm nocodazole, and decreased 74% at 18 °C. Drugs that antagonize toxin action at the nerve terminal, such as bafilomycin A1 (which prevents acidification of endosomes) and methylamine HCl (which neutralizes acidification of endosomes), produced only a modest inhibitory effect on the rate of transcytosis (17–22%). These results may provide an explanation for the mechanism by which botulinum toxin escapes the human gastrointestinal tract, and they may also explain why specific serotypes cause human disease and others do not.


Gene | 1995

Cloning and sequence analysis of a cDNA encoding human syntaxin 1A, a polypeptide essential for exocytosis

Ren-de Zhang; Andrew B. Maksymowych; Lance L. Simpson

A clone encoding human syntaxin 1A was isolated and sequenced from a human brain library. The deduced sequence encodes a 288-amino-acid (aa) protein that presumably plays a critical role in neurotransmitter exocytosis and is 98.0% identical to the aa sequence of rat syntaxin 1A.


Molecular Therapy | 2006

589. Repeated Recombinant Adenovirus (rAd) Administration To Generate Mucosal Antibodies (Abs) vs Botulinum Toxin A (BoNT/A)

Marlene S. Strayer; Andrew B. Maksymowych; Carmen N. Nichols; Steven Elek; Jean-Pierre Louboutin; Lance L. Simpson; David S. Strayer

Many infectious agents enter the body via the mucosae. Thus, mucosal immunity is an important early defense and a logical vaccine target. Mucosal Abs (mainly secretory IgA, sIgA) are typically made after mucosal immunization. Adjuvants are often required to elicit a strong response. BoNT/A, one of the most potent poisons known, is a potential biological weapon. Since it can poison by inhalation, it could be aerosolized, easily disseminated and hard to inactivate.


Infection and Immunity | 1999

Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade.

Andrew B. Maksymowych; Marco Reinhard; Carl J. Malizio; Michael C. Goodnough; Eric A. Johnson; Lance L. Simpson


Journal of Pharmacology and Experimental Therapeutics | 2004

Structural Features of the Botulinum Neurotoxin Molecule That Govern Binding and Transcytosis across Polarized Human Intestinal Epithelial Cells

Andrew B. Maksymowych; Lance L. Simpson


Infection and Immunity | 1997

Induction of an immune response by oral administration of recombinant botulinum toxin.

N Kiyatkin; Andrew B. Maksymowych; Lance L. Simpson


Journal of Pharmacology and Experimental Therapeutics | 2005

Visualization of Binding and Transcytosis of Botulinum Toxin by Human Intestinal Epithelial Cells

Chowdhury R. Ahsan; György Hajnóczky; Andrew B. Maksymowych; Lance L. Simpson


Journal of Biological Chemistry | 2001

The role of zinc binding in the biological activity of botulinum toxin.

Lance L. Simpson; Andrew B. Maksymowych; Sheryl Hao


Archive | 1998

Compositions and methods for systemic delivery of oral vaccines and therapeutic agents

Lance L. Simpson; Nikita Kiyatkin; Andrew B. Maksymowych


Journal of Pharmacology and Experimental Therapeutics | 2003

The Role of the Interchain Disulfide Bond in Governing the Pharmacological Actions of Botulinum Toxin

Lance L. Simpson; Andrew B. Maksymowych; Jong-Beak Park; Roop S. Bora

Collaboration


Dive into the Andrew B. Maksymowych's collaboration.

Top Co-Authors

Avatar

Lance L. Simpson

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jong-Beak Park

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Julie A. Coffield

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carl J. Malizio

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

David S. Strayer

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Eric A. Johnson

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

György Hajnóczky

Thomas Jefferson University

View shared research outputs
Researchain Logo
Decentralizing Knowledge